Skip to main content
Premium Trial:

Request an Annual Quote

Cognia, Biobase Partner To Distribute Database To Pharma, Biotech Markets


NEW YORK--Cognia Bioinformatics, a privately held firm founded here in 1998, has announced that it will become the exclusive distributor in the US and Canada of an annotated database of transcription regulation information created by Biobase Biological Databases of Braunschweig, Germany. Biobase's Transfac database contains functional annotations of close to 2,500 transcription factors and 8,000 corresponding binding sites. Biobase said it has licensed Transfac to four large undisclosed pharmaceutical companies since the product was commercialized in November 1997. Bruno Larvol, Cognia's founder and CEO, who was previously a bioinformatics consultant at the Wilkerson Group, said, "Our market research suggests that the Transfac database has the potential to become an essential part of the bioinformatics toolkit for all major drug discovery companies."

Filed under

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.